The stated purity on a peptide product label and the actual purity of the compound in solution can differ substantially. In the unregulated research peptide market, label claims have historically been difficult to verify without independent analytical testing. Understanding how reputable suppliers verify purity — and what the analytical methods actually measure — helps researchers evaluate source credibility and research validity.
What Purity Actually Means
Purity in peptide chemistry refers to the proportion of the target peptide sequence in the final product relative to all other material: truncated sequences, deletion peptides, oxidised variants, aggregates, residual solvents, and counter-ions. A "99% purity" peptide means 99% of the UV-absorbing material detected by HPLC corresponds to the target peptide peak. It does not necessarily account for water content, TFA (trifluoroacetic acid) counter-ion content, or non-UV-absorbing contaminants.
HPLC: Reversed-Phase Chromatography
High-Performance Liquid Chromatography (HPLC) separates compounds in a mixture based on their hydrophobicity. In reversed-phase HPLC (RP-HPLC), the stationary phase is non-polar and the mobile phase is aqueous/organic. Peptides elute at different retention times based on their amino acid composition and sequence. The detector — typically UV at 220 nm, which captures peptide bond absorption — measures peak area as a proxy for quantity.
Purity is calculated as the percentage of total peak area attributed to the target peptide peak. This method is sensitive to truncated sequences (which appear as distinct peaks), oxidised methionine or cysteine variants, and isomeric impurities, but cannot detect contaminants that don't absorb UV or that co-elute with the target peak.
Mass Spectrometry Confirmation
HPLC purity tells you the proportion of target compound. Mass spectrometry (MS) — particularly electrospray ionisation MS (ESI-MS) or MALDI-TOF — confirms the molecular identity by measuring mass-to-charge ratios. A clean ESI-MS spectrum showing the expected multiply-charged ion series at the correct m/z values confirms the peptide sequence. MS does not quantify purity but rules out identity errors (wrong sequence, incomplete removal of protecting groups from synthesis).
Together, RP-HPLC and ESI-MS provide the standard evidence package for a research-grade peptide: a purity percentage and a confirmed identity. Suppliers who provide third-party certificates of analysis (COAs) with both data points offer meaningfully stronger quality assurance than label claims alone.
Practical Considerations for Researchers
Lyophilised peptides absorb moisture rapidly upon exposure to air. A COA generated at the point of manufacture may not reflect the purity of a product that has been improperly stored or repeatedly opened. Proper storage — typically −20°C, desiccated, in single-use aliquots — preserves peptide integrity. Peptides reconstituted in bacteriostatic water should be used within 30 days and stored at 4°C.
TFA counter-ion content is a specific concern for biological research. TFA is used in HPLC purification and can account for a significant proportion of peptide salt mass. High TFA content can be cytotoxic in cell-based assays. High-quality suppliers perform counter-ion exchange (typically to acetate) for products intended for biological research applications.
What to Look For in a COA
- Purity ≥98% by RP-HPLC (with chromatogram image ideally)
- ESI-MS or MALDI-TOF confirming target molecular weight
- Issuing laboratory name and date of analysis
- Batch or lot number matching the shipped product
- Net peptide content (accounting for water and counter-ions) for accurate dosing
This article is for educational purposes. Research peptides are intended for laboratory research only, not human use. Always verify supplier documentation before use in any research protocol.